GUJARAT THEMIS BIOSYN
|
The Current P/S Ratio of GUJARAT THEMIS BIOSYN is 31.16.
| Share Price | ₹444.4 | Dec 26,2025 |
| Market Cap | ₹4,844.0 Cr | |
| Sales-TTM | ₹155.5 Cr | TTM-Standalone Results |
| Price/Sales | 31.16x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of GUJARAT THEMIS BIOSYN
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,844.0 Cr] as on Dec 26,2025
(/) Sales [ ₹155.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 31.16x ]
Thus, for GUJARAT THEMIS BIOSYN , the investors are currently willing to pay '31.16 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GUJARAT THEMIS BIOSYN !
The chart below summarizes the trend in P/S Ratio of GUJARAT THEMIS BIOSYN over the last five years.
Historical PS (Price/Sales) ratio chart of GUJARAT THEMIS BIOSYN
PS Ratio Performance Analysis for GUJARAT THEMIS BIOSYN
- GUJARAT THEMIS BIOSYN 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 10.48x.
- GUJARAT THEMIS BIOSYN 's operated at median p/e ratio of 6.72x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GUJARAT THEMIS BIOSYN 's p/e ratio peaked in Mar2025 at 20.34x.
- GUJARAT THEMIS BIOSYN 's p/e ratio hit its five-year low in Mar2021 of 3.27x.
How does GUJARAT THEMIS BIOSYN 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| GUJARAT THEMIS BIOSYN | 155.5 | 31.16 | 4,844.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.50 | 412,494.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.00 | 170,514.0 |
| CIPLA LTD | 28,349.6 | 4.29 | 121,574.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.54 | 129,044.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.09 | 105,919.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.67 | 90,491.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.74 | 91,718.2 |
| LUPIN LTD | 24,750.7 | 3.90 | 96,519.3 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.15 | 70,041.8 |
| ABBOTT INDIA LTD | 6,714.4 | 9.14 | 61,350.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GUJARAT THEMIS BIOSYN 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.15x |
| Max industry PS | 31.16x |
| Median industry PS | 6.67x |
| Average industry PS | 9.02x |
You may also like the below Video Courses